Probi AB (publ)
SSE:PROB.ST
Overview | Financials
Company Name | Probi AB (publ) |
Symbol | PROB.ST |
Currency | SEK |
Price | 203 |
Market Cap | 2,313,002,300 |
Dividend Yield | 0.63% |
52-week-range | 165 - 216 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Anita Johansen |
Website | https://www.probi.com |
An error occurred while fetching data.
About Probi AB (publ)
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD